MedTrace Logo

BroadBand Light for the Treatment of Dry Eye Disease

NCT06174064 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-12-18

No results posted yet for this study

Summary

The investigators will be evaluating the use of broadband light in Dry Eye and Meibomian Gland Dysfunction.

Conditions

  • Dry Eye Syndromes
  • Meibomian Gland Dysfunction

Interventions

DEVICE

Broadband Light treatment

While shielding the eyes, multiple passes of broadband light will be applied to the upper cheeks and eyelids after applying topical lidocaine.

DEVICE

Sham broadband light treatment

The light will be occluded on the usual BBL device so that no treatment is delivered but the preparation and procedure will otherwise be the same.

Sponsors & Collaborators

  • Ophthalmic Surgeons & Consultants of Ohio, Inc.

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Sandy Zhang-Nunes, MD · USC Roski Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-07-01
Completion
2025-08-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06174064 on ClinicalTrials.gov